Michael King
Stock Analyst at EF Hutton
(0)
# 4778
Out of 5,240 analysts
132
Total ratings
28.70%
Success rate
-23.68%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Apollomics | Maintains: Buy | 1100 650 | 10.51 | 6084.59% | 4 | Apr 1, 2024 | |
Sonnet BioTherapeuti... | Assumes: Buy | 1180 | 1.51 | 77992.72% | 7 | Aug 23, 2023 | |
Lantern Pharma | Reiterates: Buy | 11 | 3.44 | 219.77% | 10 | Aug 10, 2023 | |
Biomea Fusion | Reiterates: Buy | 32 | 4.16 | 669.23% | 11 | Jun 26, 2023 | |
Jasper Therapeutics | Reiterates: Buy | 69 | 5.87 | 1066.95% | 10 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 200 | n/a | n/a | 7 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 9 | 1.35 | 514.81% | 6 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 862 | 690.23 | 24.89% | 11 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 24 | 35.65 | -32.68% | 10 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 17 | 0.62 | 2641.94% | 3 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 166 | 3.15 | 5169.84% | 7 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 42 | 19.15 | 119.32% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 304 | 240.92 | 26.18% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 123 116 | 9.68 | 1098.35% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | 1.99 | 417.59% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 28 | 0.17 | 16370.59% | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 41.52 | -42.2% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1000 800 | 2.73 | 29204.03% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 46 | 14.94 | 207.9% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 98 96 | 33.33 | 188.03% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10500 5250 | n/a | n/a | 2 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 1.08 | 3233.33% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 0.78 | 1438.46% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 31 | 7.41 | 318.35% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | n/a | n/a | 1 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 180 160 | 0.24 | 66566.67% | 4 | Oct 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 1088 544 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 33 36 | 665.84 | -94.59% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 38 | n/a | n/a | 1 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 29, 2017 |